SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 3rd, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 3rd, 2021 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 31, 2021, by and between RESPIRERX PHARMACEUTICALS INC., a Delaware corporation, with headquarters located at 126 Valley Road, Suite C, Glen Rock, NJ 07452 (the “Company”), and BARTON ASSET MANAGEMENT LLC, a Delaware limited liability company, with its address at 135 Main Street, Suite 850, San Francisco, CA 94015 (the “Buyer”).
NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Common Stock Purchase Warrant • September 3rd, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 3rd, 2021 Company Industry JurisdictionThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $115,000.00 to the Holder (as defined below) of even date) (the “Note”), Barton Asset Management LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from RESPIRERX PHARMACEUTICALS INC., a Delaware corporation (the “Company”), 5,750,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated August 31, 2021, by and among th
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • September 3rd, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 3rd, 2021 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of August 31, 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Barton Asset Management LLC a Delaware limited liability company (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.